SUPERNUS PHARMACEUTICALS INC USD0.001 financial statements, including revenue, expenses, profit, and loss

The total revenue of 0LB2 for the last quarter is 168.32 M USD, and it's 17.18% higher compared to the previous quarter. The net income of Q2 24 is 19.92 M USD.